Pharmacological disease models
Small molecules and excitotoxic agents can be used to pharmacologically induce disease models such as epilepsy, Parkinson's Disease, catalepsy, Schizophrenia, pain and diabetes models. Researchers can save up to 50% on excitotoxic agents - they are up to half the price of other suppliers.
Show/Hide Filters
EHNA hydrochloride (HB3540)
Description:Potent adenosine deaminase and PDE2 inhibitor. Supresses spontaneous hESC differentiation. Also maintains pluripotency of hESCs in the absence of exogenous cytokines.
Purity:>98%
Eliprodil (HB0274)
Description:Non-competitive, GluN2B subunit selective NMDA receptor antagonist
Purity:>98%
Empagliflozin (HB4638)
Description:Potent, selective sodium glucose co-transporter 2 (SGLT-2) inhibitor
Purity:>98%
epi-Aszonalenin A (HB3889)
Description:Derivative of aszonalenin, a substance P inhibitor.
Purity:>95%
Epoxomicin (HB3890)
Description:Potent, selective and irreversible 20S proteasome inhibitor
Purity:>97%